| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |